Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer	Ovarian Cancer Recurrent	Recruiting	Phase 2 / Phase 3	2025-03-18		NCT06791460

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Obstetrics & Gynecology Hospital of Fudan University	36

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Obstetrics and Gynecology Hospital of Fudan University	Shanghai	China	2

Clinical trials